Basic Information
| RNALocate ID: | RLID:11001489 |
| RNA Symbol: | hsa-miR-210-3p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-210 |
| RNA ID: | miRBase:MIMAT0000267 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 23663360 |
| Tissue/Cell Line: | Plasma |
| Method: | Next-generation RNA sequencing |
| Description: | Because the abundance of most miRNAs is low in the exosomes, we defined detectable miRNAs as those that had at least one sequence per million mappable miRNA reads. Accordingly, we detected a total of 593 known miRNAs in the 14 libraries. In each individual library, the number of detectable known miRNAs varied from 380 to 474 with an average of 419 [see Additional file 2]. Data are collected from Additional file 2: Read counts of the miRNAs detected in the 14 libraries (normalized to read number per million mappable miRNA seqeuences). |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01001647 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001648 | Mitochondrion | Myotube | 27396686 |
| RLID:01001649 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
| RLID:01001650 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
| RLID:01001651 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001652 | Nucleus | Colon adenocarcinoma cells | 20864815 |
| RLID:01001653 | Nucleus | Neural progenitor cells | 21363885 |
| RLID:11001485 | Exosome | Plasma | 19289371 |
| RLID:11001486 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
| RLID:11001487 | Exosome | Breast milk | 22211110 |
| RLID:11001488 | Exosome | Brain tissue | 23382797 |
| RLID:11001490 | Exosome | Human mast cell line (HMC-1) | 24009880 |
| RLID:11001491 | Microvesicle | Seminal plasma | 23539611 |
| RLID:11001492 | Microvesicle | Follicular fluid | 23666971 |
| RLID-D:11000058 | Exosome | B lymphoblastoid cells|Endothelial cells|Epithelial cells|Lymphoma tissue|Mast cells|Tongue tissue | |
| RLID-D:11000328 | Microvesicle | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-210-3p | Diffuse large b cell lymphoma | MNDR-E-MI-28404 |
| MNDR | hsa-miR-210-3p | Splenic marginal zone lymphoma | MNDR-E-MI-28405 |
| MNDR | hsa-miR-210-3p | Pheochromocytoma | MNDR-E-MI-28406 |
| MNDR | hsa-miR-210-3p | Multiple sclerosis chronic progressive | MNDR-E-MI-28407 |
| MNDR | hsa-miR-210-3p | Peripheral artery disease | MNDR-E-MI-28408 |
| MNDR | hsa-miR-210-3p | Oral squamous cell carcinoma | MNDR-E-MI-28409 |
| MNDR | hsa-miR-210-3p | Large cell neuroendocrine cancer | MNDR-E-MI-28410 |
| MNDR | hsa-miR-210-3p | Follicular lymphoma | MNDR-E-MI-28411 |
| MNDR | hsa-miR-210-3p | Medulloblastoma | MNDR-E-MI-28412 |
| MNDR | hsa-miR-210-3p | High-grade serous ovarian carcinoma | MNDR-E-MI-28413 |
| MNDR | hsa-miR-210-3p | Uterine corpus endometrial carcinoma | MNDR-E-MI-28414 |
| MNDR | hsa-miR-210-3p | Lymphoma non-hodgkin | MNDR-E-MI-28415 |
| MNDR | hsa-miR-210-3p | Estrogen-receptor positive breast cancer | MNDR-E-MI-28416 |
| MNDR | hsa-miR-210-3p | Estrogen-receptor negative breast cancer | MNDR-E-MI-28417 |
| MNDR | hsa-miR-210-3p | Progesterone-receptor positive breast cancer | MNDR-E-MI-28418 |
| MNDR | hsa-miR-210-3p | Progesterone-receptor negative breast cancer | MNDR-E-MI-28419 |
| MNDR | hsa-miR-210-3p | Her2-receptor positive breast cancer | MNDR-E-MI-28420 |
| MNDR | hsa-miR-210-3p | Acute promyelocytic leukemia | MNDR-E-MI-28421 |
| MNDR | hsa-miR-210-3p | Breast cancer luminal | MNDR-E-MI-28422 |
| MNDR | hsa-miR-210-3p | Niemann-pick disease type c | MNDR-E-MI-28423 |
| MNDR | hsa-miR-210-3p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-28424 |
| MNDR | hsa-miR-210-3p | Osteonecrosis | MNDR-E-MI-28425 |
| MNDR | hsa-miR-210-3p | Dermatomyositis | MNDR-E-MI-28426 |
| MNDR | hsa-miR-210-3p | Prostate cancer | MNDR-E-MI-28427 |
| MNDR | hsa-miR-210-3p | Gastric cancer | MNDR-E-MI-28428 |
| MNDR | hsa-miR-210-3p | Gastric lymphoma | MNDR-E-MI-28429 |
| MNDR | hsa-miR-210-3p | Pre-eclampsia | MNDR-E-MI-28430 |
| MNDR | hsa-miR-210-3p | Alzheimer disease | MNDR-E-MI-28431 |
| MNDR | hsa-miR-210-3p | Intracranial aneurysm | MNDR-E-MI-28432 |
| MNDR | hsa-miR-210-3p | Bladder cancer | MNDR-E-MI-28433 |
| MNDR | hsa-miR-210-3p | Esophageal carcinoma | MNDR-E-MI-28434 |
| MNDR | hsa-miR-210-3p | Dysautonomia familial | MNDR-E-MI-28435 |
| MNDR | hsa-miR-210-3p | Head and neck cancer | MNDR-E-MI-28436 |
| MNDR | hsa-miR-210-3p | Graves disease | MNDR-E-MI-28437 |
| MNDR | hsa-miR-210-3p | Leukemia | MNDR-E-MI-28438 |
| MNDR | hsa-miR-210-3p | Cardiovascular disease | MNDR-E-MI-28439 |
| MNDR | hsa-miR-210-3p | Lung cancer | MNDR-E-MI-28440 |
| MNDR | hsa-miR-210-3p | Parkinson disease | MNDR-E-MI-28441 |
| MNDR | hsa-miR-210-3p | Niemann-pick disease | MNDR-E-MI-28442 |
| MNDR | hsa-miR-210-3p | Breast cancer | MNDR-E-MI-28443 |
| MNDR | hsa-miR-210-3p | Pituitary neoplasms | MNDR-E-MI-28444 |
| MNDR | hsa-miR-210-3p | Pancreatic cancer | MNDR-E-MI-28445 |
| MNDR | hsa-miR-210-3p | Melanoma | MNDR-E-MI-28446 |
| MNDR | hsa-miR-210-3p | Atherosclerosis | MNDR-E-MI-28447 |
| MNDR | hsa-miR-210-3p | Hepatitis B | MNDR-E-MI-28448 |
| MNDR | hsa-miR-210-3p | Nephroblastoma | MNDR-E-MI-28449 |
| MNDR | hsa-miR-210-3p | Colon cancer | MNDR-E-MI-28450 |
| MNDR | hsa-miR-210-3p | Ischemic attack transient | MNDR-E-MI-28451 |
| MNDR | hsa-miR-210-3p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-28452 |
| MNDR | hsa-miR-210-3p | Familial ovarian cancer | MNDR-E-MI-28453 |
| MNDR | hsa-miR-210-3p | Prostate adenocarcinoma | MNDR-E-MI-28454 |
| MNDR | hsa-miR-210-3p | Kidney cancer | MNDR-E-MI-28455 |
| MNDR | hsa-miR-210-3p | Carcinoma ductal breast | MNDR-E-MI-28456 |
| MNDR | hsa-miR-210-3p | Balkan nephropathy | MNDR-E-MI-28457 |
| MNDR | hsa-miR-210-3p | Glioblastoma | MNDR-E-MI-28458 |
| MNDR | hsa-miR-210-3p | Astrocytoma | MNDR-E-MI-28459 |
| MNDR | hsa-miR-210-3p | Glioma | MNDR-E-MI-28460 |
| MNDR | hsa-miR-210-3p | Gastrointestinal system cancer | MNDR-E-MI-28461 |
| MNDR | hsa-miR-210-3p | Oligodendroglioma | MNDR-E-MI-28462 |
| MNDR | hsa-miR-210-3p | Nemaline myopathy | MNDR-E-MI-28463 |
| MNDR | hsa-miR-210-3p | Amyotrophic lateral sclerosis | MNDR-E-MI-28464 |
| MNDR | hsa-miR-210-3p | Epilepsy temporal lobe | MNDR-E-MI-28465 |
| MNDR | hsa-miR-210-3p | Osteosarcoma | MNDR-E-MI-28466 |
| MNDR | hsa-miR-210-3p | Breast carcinoma | MNDR-E-MI-28467 |
| MNDR | hsa-miR-210-3p | Pancreatic ductal adenocarcinoma | MNDR-E-MI-28468 |
| MNDR | hsa-miR-210-3p | Cerebral infarction | MNDR-E-MI-28469 |
| MNDR | hsa-miR-210-3p | Meningioma | MNDR-E-MI-28470 |
| MNDR | hsa-miR-210-3p | Uterine cancer | MNDR-E-MI-28471 |
| MNDR | hsa-miR-210-3p | Cervical adenocarcinoma | MNDR-E-MI-28472 |
| MNDR | hsa-miR-210-3p | Gastric adenocarcinoma | MNDR-E-MI-28473 |
| MNDR | hsa-miR-210-3p | Cervical squamous cell carcinoma | MNDR-E-MI-28474 |
| MNDR | hsa-miR-210-3p | Pituitary adenoma | MNDR-E-MI-28475 |
| MNDR | hsa-miR-210-3p | Lung squamous cell carcinoma | MNDR-E-MI-28476 |
| MNDR | hsa-miR-210-3p | Carcinoma lung non-small-cell | MNDR-E-MI-28477 |
| MNDR | hsa-miR-210-3p | Lung adenocarcinoma | MNDR-E-MI-28478 |
| MNDR | hsa-miR-210-3p | Adrenocortical cancer | MNDR-E-MI-28479 |
| MNDR | hsa-miR-210-3p | Thyroid carcinoma | MNDR-E-MI-28480 |
| MNDR | hsa-miR-210-3p | Ovarian carcinoma | MNDR-E-MI-28481 |
| MNDR | hsa-miR-210-3p | Bladder urothelial carcinoma | MNDR-E-MI-28482 |
| MNDR | hsa-miR-210-3p | Pancreatic adenocarcinoma | MNDR-E-MI-28483 |
| MNDR | hsa-miR-210-3p | Myasthenia gravis autoimmune experimental | MNDR-E-MI-28484 |
| MNDR | hsa-miR-210-3p | Kidney renal clear cell carcinoma | MNDR-E-MI-28485 |
| MNDR | hsa-miR-210-3p | Kidney renal papillary cell carcinoma | MNDR-E-MI-28486 |
| MNDR | hsa-miR-210-3p | Clear cell renal cell carcinoma | MNDR-E-MI-28487 |
| MNDR | hsa-miR-210-3p | Large cell carcinoma | MNDR-E-MI-28488 |
| MNDR | hsa-miR-210-3p | Intrahepatic cholangiocarcinoma | MNDR-E-MI-28489 |
| MNDR | hsa-miR-210-3p | Cholangiocarcinoma | MNDR-E-MI-28490 |
| MNDR | hsa-miR-210-3p | Esophageal cancer | MNDR-E-MI-28491 |
| MNDR | hsa-miR-210-3p | Liver cirrhosis | MNDR-E-MI-28492 |
| MNDR | hsa-miR-210-3p | Lung small cell carcinoma | MNDR-E-MI-28493 |
| MNDR | hsa-miR-210-3p | Head and neck squamous cell carcinoma | MNDR-E-MI-28494 |
| MNDR | hsa-miR-210-3p | Myocardial infarction | MNDR-E-MI-28495 |
| MNDR | hsa-miR-210-3p | Encephalomyelitis | MNDR-E-MI-28496 |
| MNDR | hsa-miR-210-3p | Pulmonary hypertension | MNDR-E-MI-28497 |
| MNDR | hsa-miR-210-3p | Breast invasive carcinoma | MNDR-E-MI-28498 |
| MNDR | hsa-miR-210-3p | Early hepatocellular carcinoma | MNDR-E-MI-28499 |
| MNDR | hsa-miR-210-3p | Familiar ovarian carcinoma | MNDR-E-MI-28500 |
| MNDR | hsa-miR-210-3p | B-cell lymphoma | MNDR-E-MI-28501 |
| MNDR | hsa-miR-210-3p | Rheumatoid arthritis | MNDR-E-MI-28502 |
| MNDR | hsa-miR-210-3p | Malignant pleural mesothelioma | MNDR-E-MI-28503 |
| MNDR | hsa-miR-210-3p | Retinoblastoma | MNDR-E-MI-28504 |
| MNDR | hsa-miR-210-3p | Burkitt lymphoma | MNDR-E-MI-28505 |
| MNDR | hsa-miR-210-3p | Acute myelogenous leukemia | MNDR-E-MI-28506 |
| MNDR | hsa-miR-210-3p | Colorectal cancer | MNDR-E-MI-28507 |
| MNDR | hsa-miR-210-3p | Multiple myeloma | MNDR-E-MI-28508 |
| MNDR | hsa-miR-210-3p | Esophageal squamous cell carcinoma | MNDR-E-MI-28509 |
| MNDR | hsa-miR-210-3p | Ependymoma | MNDR-E-MI-28510 |
| MNDR | hsa-miR-210-3p | Polymyositis | MNDR-E-MI-28511 |
| MNDR | hsa-miR-210-3p | Subarachnoid hemorrhage traumatic | MNDR-E-MI-28512 |
| MNDR | hsa-miR-210-3p | Brain injury chronic | MNDR-E-MI-28513 |
| MNDR | hsa-miR-210-3p | Gallstones | MNDR-E-MI-28514 |
| MNDR | hsa-miR-210-3p | Stroke lacunar | MNDR-E-MI-28515 |
| MNDR | hsa-miR-210-3p | Breast cancer her3+ negative | MNDR-E-MI-28516 |
| MNDR | hsa-miR-210-3p | Duke C | MNDR-E-MI-28517 |
| MNDR | hsa-miR-210-3p | High grade dysplastic nodule | MNDR-E-MI-28518 |
| MNDR | hsa-miR-210-3p | Laryngocarcinoma cancer | MNDR-E-MI-28519 |
| MNDR | hsa-miR-210-3p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-28520 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ABCB9 | Homo sapiens | RR00023200 |
TOP